Market Cap 6.92M
Revenue (ttm) 2.29M
Net Income (ttm) -18.63M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -813.54%
Debt to Equity Ratio 0.47
Volume 117,200
Avg Vol 101,437
Day's Range N/A - N/A
Shares Out 3.02M
Stochastic %K 10%
Beta -2.08
Analysts Strong Sell
Price Target $30.00

Company Profile

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual b...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 770 500 3910
Fax: 404 581 5903
Website: femasys.com
Address:
3950 Johns Creek Court, Suite 100, Suwanee, United States
prismmarketview
prismmarketview Aug. 17 at 2:28 PM
$FEMY Femasys Inc. strengthens its funding base with a completed $30M private placement led by Nantahala Capital, with potential total proceeds of up to $90M upon full cash exercise of warrants. Key focuses: -Build U.S. commercial execution for FemaSeed -Advance FemBloc’s U.S. pivotal clinical program -Support regulatory work toward potential U.S. approval -Expand access to fertility and non-surgical permanent birth-control solutions. https://prismmarketview.com/femasys-bolsters-its-growth-plan-with-30-million-financing-as-fembloc-and-femaseed-programs-advance/ #FEMY #WomensHealth #Fertility #MedicalDevices
0 · Reply
cjw1979
cjw1979 Aug. 17 at 2:26 PM
$FEMY it's all noise until real commercialization. If you think they'll make it, then get in when you like. If you don't, then don't. I think they have a good chance. Right now they're looking g-ddamn cheap. Buying more.
0 · Reply
TwizzlersForSale
TwizzlersForSale Aug. 17 at 1:51 PM
0 · Reply
4RiskyBusiness4
4RiskyBusiness4 Aug. 17 at 1:06 PM
$FEMY Two beats, EPS, and Revenue. Plenty of gas in the tank to get to thr next leg of the journey, even while sales dou led YOY.
0 · Reply
Airdvl
Airdvl Aug. 17 at 11:26 AM
$FEMY before I decided to find one stock, mistake, i was a scalper. Really only got decent at it in the last couple of years before I bought this stock. I had l learned to do better research and stuck to the 6% loss rule. Then i got tired of spending so much time with it and was looking for a stock i could believe in. I found it here. I dont have lot of capitol but kept scalping till i got 100,000 shares. Now only 5,000. I will scalp this all the way back to 23 dollars then higher. I know this will be 25 to over 100 when i am done. May take 4 years or 4 days. I will be there. I hope those of you in my same boat make it too. And I pray that when we are done we will live in a democratic society where there are NO poor people and our children dont have to see the meat grinder that is WAR. (amen).
1 · Reply
Zaksab
Zaksab Aug. 17 at 10:39 AM
$FEMY 😂
0 · Reply
ViGx
ViGx Aug. 16 at 6:24 PM
$FEMY One thing for sure...Charts, Slides, Conferences, Powerpoint Presentations,....consider them for what they are...nothing..Look at the ER... that's all....
2 · Reply
ZeroJobZeroProblem
ZeroJobZeroProblem Aug. 15 at 10:11 PM
$FEMY The promise of FDA approval and adoption in the US. They aren't the only ones waiting for their pay day. There's been many promises from the CEO right? They believe. Just because we aren't there yet, doesn't mean a different CEO could have taken this over the finish line faster. - R&D / Product Development time - Clinical Development / Trials time - Regulatory Approval / Clearance time - Manufacturing / Scale-Up time - Commercialization / Market Launch time - Market Adoption & Growth time Not to mention we are at diff stages for diff products, as I see it. FemVue / FemCerv / FemCath: Already through regulatory clearance and commercialization. FemaSeed + FemSperm: Cleared/available and moving through the commercialization and adoption stage. FemBloc: Already approved and being commercialized in certain international markets, while in the U.S. it is still in the pivotal clinical trial, up next is FDA authorization stage. Enrollment in the U.S. FINALE trial began in March 2026.
3 · Reply
beaches911
beaches911 Aug. 15 at 2:51 PM
$FEMY Completely dead stock until they get Fembloc approved in the US. Their other products the cost of generating additional sales for them means it will be years after fembloc gets approved before they have meaningful sales on them, so there will be nothing positive for a long time. Grossly mismanaged by a clueless CEO.
1 · Reply
Severian1
Severian1 Aug. 15 at 12:35 PM
$FEMY pre split we are at 11.5 cents. absolutely brutal. id venture to say there will be one more before real sp growth
0 · Reply
Latest News on FEMY
Femasys issued patent for FemBloc blended polymer component

2026-08-17T09:26:25.000Z - 6 hours ago

Femasys issued patent for FemBloc blended polymer component


Femasys price target lowered to $10 from $30 at Maxim

2026-08-16T13:22:48.000Z - 1 day ago

Femasys price target lowered to $10 from $30 at Maxim


Femasys Earnings release: Q2 2026

Aug 14, 2026, 7:00 AM EDT - 3 days ago

Femasys Earnings release: Q2 2026


Femasys Quarterly report: Q2 2026

Aug 14, 2026, 7:00 AM EDT - 3 days ago

Femasys Quarterly report: Q2 2026


Femasys announces $30M private placement

2026-08-07T13:50:44.000Z - 10 days ago

Femasys announces $30M private placement


Femasys regains compliance with Nasdaq

2026-06-24T13:15:18.000Z - 7 weeks ago

Femasys regains compliance with Nasdaq


Femasys Regains Compliance with Nasdaq Listing Requirements

Jun 24, 2026, 9:00 AM EDT - 7 weeks ago

Femasys Regains Compliance with Nasdaq Listing Requirements


Femasys Inc trading halted, news pending

2026-06-05T23:55:32.000Z - 2 months ago

Femasys Inc trading halted, news pending


Femasys announces CE Mark approval for FemHSG Catheter

2026-05-13T14:46:53.000Z - 3 months ago

Femasys announces CE Mark approval for FemHSG Catheter


Femasys Slides: Corporate presentation

May 13, 2026, 7:00 AM EDT - 3 months ago

Femasys Slides: Corporate presentation


Femasys Quarterly report: Q1 2026

May 8, 2026, 8:00 AM EDT - 3 months ago

Femasys Quarterly report: Q1 2026


Femasys Earnings release: Q1 2026

May 8, 2026, 8:00 AM EDT - 3 months ago

Femasys Earnings release: Q1 2026


Femasys Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 3 months ago

Femasys Proxy statement: Proxy filing


Femasys Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 3 months ago

Femasys Proxy statement: Proxy filing


Femasys Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 4 months ago

Femasys Proxy statement: Proxy filing


Femasys Annual report: Q4 2025

Mar 31, 2026, 8:00 AM EDT - 4 months ago

Femasys Annual report: Q4 2025


Femasys Earnings release: Q4 2025

Mar 31, 2026, 8:00 AM EDT - 4 months ago

Femasys Earnings release: Q4 2025


Femasys Proxy statement: Proxy filing

Mar 27, 2026, 8:00 AM EDT - 5 months ago

Femasys Proxy statement: Proxy filing


Femasys management to meet virtually with Lake Street

2026-03-24T15:20:53.000Z - 5 months ago

Femasys management to meet virtually with Lake Street


Femasys appoints Kenneth Eichenbaum to its Board of Directors

2026-03-18T13:05:27.000Z - 5 months ago

Femasys appoints Kenneth Eichenbaum to its Board of Directors


Femasys initiated with a Buy at Lake Street

2026-03-03T13:13:48.000Z - 5 months ago

Femasys initiated with a Buy at Lake Street


Femasys FemBloc achieved certification under MDSAP

2026-02-26T14:06:51.000Z - 6 months ago

Femasys FemBloc achieved certification under MDSAP


Femasys enters distribution partnership with OR Consulting

2026-02-03T14:20:28.000Z - 6 months ago

Femasys enters distribution partnership with OR Consulting


Femasys announces partnership with Refuah Health Center

2026-01-13T14:05:24.000Z - 7 months ago

Femasys announces partnership with Refuah Health Center


Femasys files to sell 68.42M shares of common stock for holders

2025-12-31T21:40:10.000Z - 8 months ago

Femasys files to sell 68.42M shares of common stock for holders


Femasys Registration statement: Registration filing

Dec 31, 2025, 7:00 AM EST - 8 months ago

Femasys Registration statement: Registration filing


Femasys secures U.S. FDA clearance for FemVue Controlled device

2025-12-18T14:21:29.000Z - 8 months ago

Femasys secures U.S. FDA clearance for FemVue Controlled device


Femasys Registration statement: Registration filing

Dec 4, 2025, 7:00 AM EST - 9 months ago

Femasys Registration statement: Registration filing


Femasys Quarterly report: Q3 2025

Nov 14, 2025, 7:00 AM EST - 9 months ago

Femasys Quarterly report: Q3 2025


Femasys Earnings release: Q3 2025

Nov 14, 2025, 7:00 AM EST - 9 months ago

Femasys Earnings release: Q3 2025


Femasys to Exhibit at the ASRM 2025 Scientific Congress & Expo

Oct 16, 2025, 9:00 AM EDT - 10 months ago

Femasys to Exhibit at the ASRM 2025 Scientific Congress & Expo


Femasys Registration statement: Registration filing

Aug 21, 2025, 8:00 AM EDT - 1 year ago

Femasys Registration statement: Registration filing


Femasys Registration statement: Registration filing

Aug 20, 2025, 8:00 AM EDT - 1 year ago

Femasys Registration statement: Registration filing


Femasys Announces Second Quarter Financial Results for 2025

Aug 8, 2025, 4:05 PM EDT - 1 year ago

Femasys Announces Second Quarter Financial Results for 2025


Femasys Quarterly report: Q2 2025

Aug 8, 2025, 8:00 AM EDT - 1 year ago

Femasys Quarterly report: Q2 2025


Femasys Earnings release: Q2 2025

Aug 8, 2025, 8:00 AM EDT - 1 year ago

Femasys Earnings release: Q2 2025


Femasys Registration statement: Registration filing

Jul 3, 2025, 8:00 AM EDT - 1 year ago

Femasys Registration statement: Registration filing


Femasys Quarterly report: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Femasys Quarterly report: Q1 2025


Femasys Earnings release: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Femasys Earnings release: Q1 2025


Femasys Proxy statement: Proxy filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Femasys Proxy statement: Proxy filing


Femasys Proxy statement: Proxy filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Femasys Proxy statement: Proxy filing


Femasys Annual report: Q4 2024

Mar 27, 2025, 8:00 AM EDT - 1 year ago

Femasys Annual report: Q4 2024


Femasys Earnings release: Q4 2024

Mar 27, 2025, 8:00 AM EDT - 1 year ago

Femasys Earnings release: Q4 2024


Femasys Quarterly report: Q3 2024

Nov 12, 2024, 7:00 AM EST - 1 year ago

Femasys Quarterly report: Q3 2024


Femasys Earnings release: Q3 2024

Nov 12, 2024, 7:00 AM EST - 1 year ago

Femasys Earnings release: Q3 2024


Femasys Hosts Congresswoman Lucy McBath at Georgia Headquarters

Aug 27, 2024, 8:30 AM EDT - 2 years ago

Femasys Hosts Congresswoman Lucy McBath at Georgia Headquarters


Femasys Quarterly report: Q2 2024

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Femasys Quarterly report: Q2 2024


Femasys Earnings release: Q2 2024

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Femasys Earnings release: Q2 2024


Femasys Proxy statement: Proxy filing

Jun 7, 2024, 8:00 AM EDT - 2 years ago

Femasys Proxy statement: Proxy filing


prismmarketview
prismmarketview Aug. 17 at 2:28 PM
$FEMY Femasys Inc. strengthens its funding base with a completed $30M private placement led by Nantahala Capital, with potential total proceeds of up to $90M upon full cash exercise of warrants. Key focuses: -Build U.S. commercial execution for FemaSeed -Advance FemBloc’s U.S. pivotal clinical program -Support regulatory work toward potential U.S. approval -Expand access to fertility and non-surgical permanent birth-control solutions. https://prismmarketview.com/femasys-bolsters-its-growth-plan-with-30-million-financing-as-fembloc-and-femaseed-programs-advance/ #FEMY #WomensHealth #Fertility #MedicalDevices
0 · Reply
cjw1979
cjw1979 Aug. 17 at 2:26 PM
$FEMY it's all noise until real commercialization. If you think they'll make it, then get in when you like. If you don't, then don't. I think they have a good chance. Right now they're looking g-ddamn cheap. Buying more.
0 · Reply
TwizzlersForSale
TwizzlersForSale Aug. 17 at 1:51 PM
0 · Reply
4RiskyBusiness4
4RiskyBusiness4 Aug. 17 at 1:06 PM
$FEMY Two beats, EPS, and Revenue. Plenty of gas in the tank to get to thr next leg of the journey, even while sales dou led YOY.
0 · Reply
Airdvl
Airdvl Aug. 17 at 11:26 AM
$FEMY before I decided to find one stock, mistake, i was a scalper. Really only got decent at it in the last couple of years before I bought this stock. I had l learned to do better research and stuck to the 6% loss rule. Then i got tired of spending so much time with it and was looking for a stock i could believe in. I found it here. I dont have lot of capitol but kept scalping till i got 100,000 shares. Now only 5,000. I will scalp this all the way back to 23 dollars then higher. I know this will be 25 to over 100 when i am done. May take 4 years or 4 days. I will be there. I hope those of you in my same boat make it too. And I pray that when we are done we will live in a democratic society where there are NO poor people and our children dont have to see the meat grinder that is WAR. (amen).
1 · Reply
Zaksab
Zaksab Aug. 17 at 10:39 AM
$FEMY 😂
0 · Reply
ViGx
ViGx Aug. 16 at 6:24 PM
$FEMY One thing for sure...Charts, Slides, Conferences, Powerpoint Presentations,....consider them for what they are...nothing..Look at the ER... that's all....
2 · Reply
ZeroJobZeroProblem
ZeroJobZeroProblem Aug. 15 at 10:11 PM
$FEMY The promise of FDA approval and adoption in the US. They aren't the only ones waiting for their pay day. There's been many promises from the CEO right? They believe. Just because we aren't there yet, doesn't mean a different CEO could have taken this over the finish line faster. - R&D / Product Development time - Clinical Development / Trials time - Regulatory Approval / Clearance time - Manufacturing / Scale-Up time - Commercialization / Market Launch time - Market Adoption & Growth time Not to mention we are at diff stages for diff products, as I see it. FemVue / FemCerv / FemCath: Already through regulatory clearance and commercialization. FemaSeed + FemSperm: Cleared/available and moving through the commercialization and adoption stage. FemBloc: Already approved and being commercialized in certain international markets, while in the U.S. it is still in the pivotal clinical trial, up next is FDA authorization stage. Enrollment in the U.S. FINALE trial began in March 2026.
3 · Reply
beaches911
beaches911 Aug. 15 at 2:51 PM
$FEMY Completely dead stock until they get Fembloc approved in the US. Their other products the cost of generating additional sales for them means it will be years after fembloc gets approved before they have meaningful sales on them, so there will be nothing positive for a long time. Grossly mismanaged by a clueless CEO.
1 · Reply
Severian1
Severian1 Aug. 15 at 12:35 PM
$FEMY pre split we are at 11.5 cents. absolutely brutal. id venture to say there will be one more before real sp growth
0 · Reply
steve04240
steve04240 Aug. 15 at 2:09 AM
$FEMY cmon you fuckrrsssssss
0 · Reply
harryR77
harryR77 Aug. 14 at 9:36 PM
$FEMY what a useless company. Wrong CEO but great products. How the fuck can sales go down??
1 · Reply
Alican1994
Alican1994 Aug. 14 at 9:16 PM
0 · Reply
Severian1
Severian1 Aug. 14 at 9:14 PM
$FEMY yeah. they hadnt announced any new contracts or big orders in forever. revenue being a let down here is not surprising
0 · Reply
TripTrap
TripTrap Aug. 14 at 9:00 PM
$FEMY Okay, so dug into the actual 10-Q, not just the headline. The detail that will likely be missed: they raised sales and marketing spend about 38% for the first half, $2.6M vs $1.9M last year. So the “they do nothing commercially” take is just wrong. The money’s going into the sales push. However, revenue was flat to down while they spent more. That’s the issue. Commercial investment is clearly ramping, the revenue proof is the next shoe that has to drop. Operating burn is around $5M a quarter, so the $30M gives them roughly six quarters. That’s enough runway to reach the 2027 reimbursement code and achieve real progress. Funded, spending to sell, no more excuses. Next couple quarters tell the story.  It has not been fun, but I’m still holding.
3 · Reply
Ked1977
Ked1977 Aug. 14 at 8:18 PM
$FEMY the new investors need to replace the board and management. All they’ve increased is salaries and bonuses. And John Canning should not only be fired but claw back the miney he’s been paid. What a complete waste. He’s done nothing but collect a bloated paycheck. This stock is a joke. FK Kathy the narcissistic grifter.
0 · Reply
ididathing9999
ididathing9999 Aug. 14 at 8:13 PM
$FEMY Regarding the $30 million infusion they write "Management believes the additional capital provides the financial resources necessary to support the Company's strategic priorities, including the execution of its commercial initiatives, advancement of its clinical programs, and pursuit of key operational objectives." But with sales declining Q2 compared to Q1 and the company burning over $4 million last quarter... how is 7 quarters of cash runway enough for them to accomplish anything that they couldn't already accomplish?
0 · Reply
ZeroJobZeroProblem
ZeroJobZeroProblem Aug. 14 at 8:11 PM
$FEMY So basically shitty all the way around.... so the stock should soar.
0 · Reply
Alican1994
Alican1994 Aug. 14 at 12:42 PM
$FEMY all in
2 · Reply
steve04240
steve04240 Aug. 14 at 11:30 AM
$FEMY need to break 2.40 with some volume today ahead of earni ngs....then we need to hear from management some good news about femaseed commercial adoption, revenue trajectory, the cash runway and the femblock trials! LETS GO MANAGEMENT....STEP IT UP! THEY ARE RUNNING OUT OF CHANCES TO CONVINCE INVESTORS
1 · Reply
beaches911
beaches911 Aug. 14 at 11:15 AM
$FEMY It just keeps going lower for a reason, shareholders just have not found out yet
1 · Reply
Amuldee
Amuldee Aug. 14 at 3:01 AM
$FEMY interesting so they got 30M for ~9M shares+9M warrants almost 19M shares for 30M. so avg price ~1.6 Then other 9M warrants conditions will be met as revenue 1.5M & vwap 3.8 which if earnings confirm this. So they will have almost 27M shares at 30M avg becomes more like 1.2. Finally to dump 27M shares at ~1.2-1.6 avg this should pump before dump
1 · Reply